Paralysis News and Research

RSS
Paralysis is the loss of muscle function in part of your body. It happens when something goes wrong with the way messages pass between your brain and muscles. Paralysis can be complete or partial. It can occur on one or both sides of your body. It can also occur in just one area, or it can be widespread. Paralysis of the lower half of your body, including both legs, is called paraplegia. Paralysis of the arms and legs is quadriplegia.
Asterias, CIRM sign NGA to begin AST-OPC1 study for complete cervical spinal cord injury

Asterias, CIRM sign NGA to begin AST-OPC1 study for complete cervical spinal cord injury

New telehealth system could improve quality of life for MND patients

New telehealth system could improve quality of life for MND patients

Cell transplantation treatment may benefit people with spinal cord injury

Cell transplantation treatment may benefit people with spinal cord injury

LaVision BioTec report on users of light sheet microscopy in the Miami Project to Cure Paralysis

LaVision BioTec report on users of light sheet microscopy in the Miami Project to Cure Paralysis

Loyola neurologist lists seven surprising things about strokes

Loyola neurologist lists seven surprising things about strokes

Study: People with PSP experience more severe cognitive impairments than those with PD

Study: People with PSP experience more severe cognitive impairments than those with PD

CHLA reports first confirmed case of enterovirus D68 in Los Angeles

CHLA reports first confirmed case of enterovirus D68 in Los Angeles

OMRF scientist selected to receive EMD Serono's Grant for Multiple Sclerosis Innovation

OMRF scientist selected to receive EMD Serono's Grant for Multiple Sclerosis Innovation

Placenta-derived cells are safe for MS patients

Placenta-derived cells are safe for MS patients

OSU engineers develop simple device to improve hand function after surgery

OSU engineers develop simple device to improve hand function after surgery

Enlargement of left atrial appendage may be a risk factor of strokes with cardiac origin: Finnish study

Enlargement of left atrial appendage may be a risk factor of strokes with cardiac origin: Finnish study

Northwestern scientists develop first animal model for ALS dementia

Northwestern scientists develop first animal model for ALS dementia

eSSENTIAL Accessibility, Aeroplan partner to offer desktop app for people with physical disabilities

eSSENTIAL Accessibility, Aeroplan partner to offer desktop app for people with physical disabilities

New book brings awareness to debate surrounding stem cell research

New book brings awareness to debate surrounding stem cell research

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Research to help patients suffering from severe spinal cord injuries

Research to help patients suffering from severe spinal cord injuries

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Asterias receives clearance from FDA to initiate Phase 1/2a clinical trial of AST-OPC1

Asterias receives clearance from FDA to initiate Phase 1/2a clinical trial of AST-OPC1

Mylan launches Potassium Chloride Extended-release Tablets

Mylan launches Potassium Chloride Extended-release Tablets

Blocking nerve signals could be effective treatment for stomach cancer

Blocking nerve signals could be effective treatment for stomach cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.